繁體
  • 简体中文
  • 繁體中文

熱門資訊> 正文

Blade Air Mobility第二季度业绩喜忧参半

2025-08-05 19:15

  • Blade Air Mobility press release (NASDAQ:BLDE): Q2 GAAP EPS of -$0.05 misses by $0.01.
  • Revenue of $70.8M (+4.2% Y/Y) beats by $6.72M.
  • Medical revenue increased 17.6% year-over-year in Q2 2025
  • Net loss improved by $7.6 million versus the prior year to $(3.7) million in Q2 2025; Adjusted EBITDA improved by $2.2 million versus the prior year to $3.2 million in Q2 2025(1)
  • Blade Passenger division to be sold to Joby Aviation for up to $125 million; Blade’s Medical division will remain a standalone public company, rebrand as Strata Critical Medical ("Strata")
  • Sale is expected to be Adjusted EBITDA and Free Cash Flow neutral on a go forward basis

風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。